Logo image of FEMY

FEMASYS INC (FEMY) Stock Fundamental Analysis

NASDAQ:FEMY - Nasdaq - US31447E1055 - Common Stock - Currency: USD

0.7101  -0.03 (-4.35%)

Premarket: 0.72 +0.01 (+1.39%)

Fundamental Rating

2

FEMY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of FEMY have multiple concerns. FEMY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FEMY has reported negative net income.
In the past year FEMY has reported a negative cash flow from operations.
FEMY had negative earnings in each of the past 5 years.
FEMY had a negative operating cash flow in each of the past 5 years.
FEMY Yearly Net Income VS EBIT VS OCF VS FCFFEMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

FEMY has a Return On Assets of -159.02%. This is amonst the worse of the industry: FEMY underperforms 89.30% of its industry peers.
Looking at the Return On Equity, with a value of -1057.44%, FEMY is doing worse than 89.84% of the companies in the same industry.
Industry RankSector Rank
ROA -159.02%
ROE -1057.44%
ROIC N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
FEMY Yearly ROA, ROE, ROICFEMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

Looking at the Gross Margin, with a value of 66.24%, FEMY is in the better half of the industry, outperforming 69.52% of the companies in the same industry.
FEMY's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for FEMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
FEMY Yearly Profit, Operating, Gross MarginsFEMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K

0

2. Health

2.1 Basic Checks

FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FEMY has more shares outstanding
Compared to 5 years ago, FEMY has more shares outstanding
FEMY has a worse debt/assets ratio than last year.
FEMY Yearly Shares OutstandingFEMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FEMY Yearly Total Debt VS Total AssetsFEMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -17.46, we must say that FEMY is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -17.46, FEMY is doing worse than 86.63% of the companies in the same industry.
A Debt/Equity ratio of 2.89 is on the high side and indicates that FEMY has dependencies on debt financing.
FEMY's Debt to Equity ratio of 2.89 is on the low side compared to the rest of the industry. FEMY is outperformed by 88.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.89
Debt/FCF N/A
Altman-Z -17.46
ROIC/WACCN/A
WACC7.41%
FEMY Yearly LT Debt VS Equity VS FCFFEMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.93 indicates that FEMY may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.93, FEMY is doing worse than 90.91% of the companies in the same industry.
FEMY has a Quick Ratio of 0.93. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FEMY (0.54) is worse than 92.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.54
FEMY Yearly Current Assets VS Current LiabilitesFEMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

The earnings per share for FEMY have decreased by -2.41% in the last year.
FEMY shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.97%.
The Revenue has been growing by 11.86% on average over the past years. This is quite good.
EPS 1Y (TTM)-2.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)51.97%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%112.22%

3.2 Future

Based on estimates for the next years, FEMY will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.02% on average per year.
Based on estimates for the next years, FEMY will show a very strong growth in Revenue. The Revenue will grow by 109.73% on average per year.
EPS Next Y23.8%
EPS Next 2Y26.65%
EPS Next 3Y18.21%
EPS Next 5Y13.02%
Revenue Next Year128.46%
Revenue Next 2Y144.2%
Revenue Next 3Y145.11%
Revenue Next 5Y109.73%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FEMY Yearly Revenue VS EstimatesFEMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
FEMY Yearly EPS VS EstimatesFEMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

FEMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FEMY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEMY Price Earnings VS Forward Price EarningsFEMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEMY Per share dataFEMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as FEMY's earnings are expected to grow with 18.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.65%
EPS Next 3Y18.21%

0

5. Dividend

5.1 Amount

No dividends for FEMY!.
Industry RankSector Rank
Dividend Yield N/A

FEMASYS INC

NASDAQ:FEMY (8/15/2025, 8:19:26 PM)

Premarket: 0.72 +0.01 (+1.39%)

0.7101

-0.03 (-4.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-08 2025-08-08/amc
Earnings (Next)11-10 2025-11-10
Inst Owners12%
Inst Owner Change28.88%
Ins Owners10.52%
Ins Owner Change5.27%
Market Cap23.10M
Analysts82
Price Target7.4 (942.11%)
Short Float %0.5%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.28%
Min EPS beat(2)-21.89%
Max EPS beat(2)-18.68%
EPS beat(4)0
Avg EPS beat(4)-19.25%
Min EPS beat(4)-21.89%
Max EPS beat(4)-17.65%
EPS beat(8)2
Avg EPS beat(8)-9.65%
EPS beat(12)5
Avg EPS beat(12)-4.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-68.03%
Min Revenue beat(2)-70.71%
Max Revenue beat(2)-65.36%
Revenue beat(4)0
Avg Revenue beat(4)-56.25%
Min Revenue beat(4)-72.34%
Max Revenue beat(4)-16.58%
Revenue beat(8)1
Avg Revenue beat(8)-37.83%
Revenue beat(12)1
Avg Revenue beat(12)-30.36%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-43.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-29.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.59
P/FCF N/A
P/OCF N/A
P/B 11.57
P/tB 11.92
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.05
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -159.02%
ROE -1057.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.24%
FCFM N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 2.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.92%
Cap/Sales 50.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.54
Altman-Z -17.46
F-Score4
WACC7.41%
ROIC/WACCN/A
Cap/Depr(3y)62.1%
Cap/Depr(5y)48.65%
Cap/Sales(3y)33.12%
Cap/Sales(5y)25.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y23.8%
EPS Next 2Y26.65%
EPS Next 3Y18.21%
EPS Next 5Y13.02%
Revenue 1Y (TTM)51.97%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%112.22%
Revenue Next Year128.46%
Revenue Next 2Y144.2%
Revenue Next 3Y145.11%
Revenue Next 5Y109.73%
EBIT growth 1Y-32.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-87.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.77%
OCF growth 3YN/A
OCF growth 5YN/A